Chaos and reliability in balanced spiking networks with temporal drive

by Lajoie, Guillaume, Lin, Kevin K., Shea-Brown, Eric
Published 2013

Including probe-level uncertainty in model-based gene expression clustering

by Liu, Xuejun, Lin, Kevin K, Andersen, Bogi, Rattray, Magnus
Published 2007

Phase-Amplitude Descriptions of Neural Oscillator Models

by Wedgwood, Kyle CA, Lin, Kevin K, Thul, Ruediger, Coombes, Stephen
Published 2013

The influence of multiple firing events on the formation and stability of activity patterns in continuous attractor networks

by Lyttle, David, Weitzenfeld, Alfredo, Fellous, Jean-Marc, Lin, Kevin K
Published 2013

Spatial scale and place field stability in a grid-to-place cell model of the dorsoventral axis of the hippocampus

by Lyttle, David, Gereke, Brian, Lin, Kevin K., Fellous, Jean-Marc
Published 2013

The epidermal differentiation-associated Grainyhead gene Get1/Grhl3 also regulates urothelial differentiation

by Yu, Zhengquan, Mannik, Jaana, Soto, Amelia, Lin, Kevin K, Andersen, Bogi
Published 2009

Estimating replicate time shifts using Gaussian process regression

by Liu, Qiang, Lin, Kevin K., Andersen, Bogi, Smyth, Padhraic, Ihler, Alexander
Published 2010

Bayesian detection of non-sinusoidal periodic patterns in circadian expression data

by Chudova, Darya, Ihler, Alexander, Lin, Kevin K., Andersen, Bogi, Smyth, Padhraic
Published 2009

Encoding in Balanced Networks: Revisiting Spike Patterns and Chaos in Stimulus-Driven Systems

by Lajoie, Guillaume, Lin, Kevin K., Thivierge, Jean-Philippe, Shea-Brown, Eric
Published in PLoS Comput Biol (2016)

Identification of hair cycle-associated genes from time-course gene expression profile data by using replicate variance

by Lin, Kevin K., Chudova, Darya, Hatfield, G. Wesley, Smyth, Padhraic, Andersen, Bogi
Published 2004

Circadian Clock Genes Contribute to the Regulation of Hair Follicle Cycling

by Lin, Kevin K., Kumar, Vivek, Geyfman, Mikhail, Chudova, Darya, Ihler, Alexander T., Smyth, Padhraic, Paus, Ralf, Takahashi, Joseph S., Andersen, Bogi
Published 2009

Network analysis of skin tumor progression identifies a rewired genetic architecture affecting inflammation and tumor susceptibility

by Quigley, David A, To, Minh D, Kim, Il Jin, Lin, Kevin K, Albertson, Donna G, Sjolund, Jonas, Pérez-Losada, Jesús, Balmain, Allan
Published 2011

Co-factors of LIM domains (Clims/Ldb/Nli) regulate corneal homeostasis and maintenance of hair follicle stem cells

by Xu, Xiaoman, Mannik, Jaana, Kudryavtseva, Elena, Lin, Kevin K., Flanagan, Lisa A., Spencer, Joel, Soto, Amelia, Wang, Ning, Lu, Zhongxian, Yu, Zhengquan, Monuki, Edwin S., Andersen, Bogi
Published 2007

A Quantitative Chemotherapy Genetic Interaction Map Reveals Factors Associated with PARP Inhibitor Resistance

by Hu, Hsien-Ming, Zhao, Xin, Kaushik, Swati, Robillard, Lilliane, Barthelet, Antoine, Lin, Kevin K., Shah, Khyati N., Simmons, Andy D., Raponi, Mitch, Harding, Thomas C., Bandyopadhyay, Sourav
Published in Cell Rep (2018)

Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation

by Shroff, Rachna T., Hendifar, Andrew, McWilliams, Robert R., Geva, Ravit, Epelbaum, Ron, Rolfe, Lindsey, Goble, Sandra, Lin, Kevin K., Biankin, Andrew V., Giordano, Heidi, Vonderheide, Robert H., Domchek, Susan M.
Published in JCO Precis Oncol (2018)

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

by Kondrashova, Olga, Topp, Monique, Nesic, Ksenija, Lieschke, Elizabeth, Ho, Gwo-Yaw, Harrell, Maria I., Zapparoli, Giada V., Hadley, Alison, Holian, Robert, Boehm, Emma, Heong, Valerie, Sanij, Elaine, Pearson, Richard B., Krais, John J., Johnson, Neil, McNally, Orla, Ananda, Sumitra, Alsop, Kathryn, Hutt, Karla J., Kaufmann, Scott H., Lin, Kevin K., Harding, Thomas C., Traficante, Nadia, deFazio, Anna, McNeish, Iain A., Bowtell, David D., Swisher, Elizabeth M., Dobrovic, Alexander, Wakefield, Matthew J., Scott, Clare L.
Published in Nat Commun (2018)

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

by Coleman, Robert L, Oza, Amit M, Lorusso, Domenica, Aghajanian, Carol, Oaknin, Ana, Dean, Andrew, Colombo, Nicoletta, Weberpals, Johanne I, Clamp, Andrew, Scambia, Giovanni, Leary, Alexandra, Holloway, Robert W, Gancedo, Margarita Amenedo, Fong, Peter C, Goh, Jeffrey C, O’Malley, David M, Armstrong, Deborah K, Garcia-Donas, Jesus, Swisher, Elizabeth M, Floquet, Anne, Konecny, Gottfried E, McNeish, Iain A, Scott, Clare L, Cameron, Terri, Maloney, Lara, Isaacson, Jeff, Goble, Sandra, Grace, Caroline, Harding, Thomas C, Raponi, Mitch, Sun, James, Lin, Kevin K, Giordano, Heidi, Ledermann, Jonathan A
Published in Lancet (2017)

Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma

by Kondrashova, Olga, Nguyen, Minh, Shield-Artin, Kristy, Tinker, Anna V., Teng, Nelson N.H., Harrell, Maria I., Kuiper, Michael J., Ho, Gwo-Yaw, Barker, Holly, Jasin, Maria, Prakash, Rohit, Kass, Elizabeth M., Sullivan, Meghan R., Brunette, Gregory J., Bernstein, Kara A., Coleman, Robert L., Floquet, Anne, Friedlander, Michael, Kichenadasse, Ganessan, O'Malley, David M., Oza, Amit, Sun, James, Robillard, Liliane, Maloney, Lara, Giordano, Heidi, Wakefield, Matthew J., Kaufmann, Scott H., Simmons, Andrew D., Harding, Thomas C., Raponi, Mitch, McNeish, Iain A., Swisher, Elizabeth M., Lin, Kevin K., Scott, Clare L.
Published in Cancer Discov (2017)

Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)

by Swisher, Elizabeth M., Kwan, Tanya T., Oza, Amit M., Tinker, Anna V., Ray-Coquard, Isabelle, Oaknin, Ana, Coleman, Robert L., Aghajanian, Carol, Konecny, Gottfried E., O’Malley, David M., Leary, Alexandra, Provencher, Diane, Welch, Stephen, Chen, Lee-may, Wahner Hendrickson, Andrea E., Ma, Ling, Ghatage, Prafull, Kristeleit, Rebecca S., Dorigo, Oliver, Musafer, Ashan, Kaufmann, Scott H., Elvin, Julia A., Lin, Douglas I., Chambers, Setsuko K., Dominy, Erin, Vo, Lan-Thanh, Goble, Sandra, Maloney, Lara, Giordano, Heidi, Harding, Thomas, Dobrovic, Alexander, Scott, Clare L., Lin, Kevin K., McNeish, Iain A.
Published in Nat Commun (2021)

Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance

by Hurley, Rachel M, McGehee, Cordelia D, Nesic, Ksenija, Correia, Cristina, Weiskittel, Taylor M, Kelly, Rebecca L, Venkatachalam, Annapoorna, Hou, Xiaonan, Pathoulas, Nicholas M, Meng, X Wei, Kondrashova, Olga, Radke, Marc R, Schneider, Paula A, Flatten, Karen S, Peterson, Kevin L, Becker, Marc A, Wong, Ee Ming, Southey, Melissa S, Dobrovic, Alexander, Lin, Kevin K, Harding, Thomas C, McNeish, Iain, Ross, Christian A, Wagner, Jill M, Wakefield, Matthew J, Scott, Clare L, Haluska, Paul, Wahner Hendrickson, Andrea E, Karnitz, Larry M, Swisher, Elizabeth M, Li, Hu, Weroha, S John, Kaufmann, Scott H
Published in NAR Cancer (2021)